Literature DB >> 8128688

Pentoxifylline for ischemic pain in pseudoxanthoma elasticum.

T K Takaro1, G O Coodley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8128688      PMCID: PMC1022466     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  10 in total

Review 1.  Current and potential therapeutic effects of pentoxifylline.

Authors:  G P Stellin; K Waxman
Journal:  Compr Ther       Date:  1989-05

2.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

Authors:  G H Guyatt; J L Keller; R Jaeschke; D Rosenbloom; J D Adachi; M T Newhouse
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

3.  White blood cells as mediators of hyperviscosity-induced tissue damage in neutrophilic vascular reactions: therapy with pentoxifylline.

Authors:  H Ely
Journal:  J Am Acad Dermatol       Date:  1989-04       Impact factor: 11.527

4.  Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).

Authors:  D Seiffge; K U Weithmann
Journal:  Semin Thromb Hemost       Date:  1989-04       Impact factor: 4.180

5.  Pseudoxanthoma elasticum (Grönblad-Strandberg syndrome).

Authors:  D Viljoen
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

6.  Pseudoxanthoma elasticum. An underdiagnosed genetically heterogeneous disorder with protean manifestations.

Authors:  L K Altman; P J Fialkow; F Parker; R W Sagebiel
Journal:  Arch Intern Med       Date:  1974-12

Review 7.  Pentoxifylline therapy in dermatology. A review of localized hyperviscosity and its effects on the skin.

Authors:  H Ely
Journal:  Dermatol Clin       Date:  1988-10       Impact factor: 3.478

8.  Pseudoxanthoma elasticum.

Authors:  M W Engelman; M T Fliegelman
Journal:  Cutis       Date:  1978-06

9.  Anti-inflammatory effects of pentoxifylline in claudication.

Authors:  M S Currie; D L Simel; R H Christenson; C Holmes; J Crawford; H J Cohen; K M Rao
Journal:  Am J Med Sci       Date:  1991-02       Impact factor: 2.378

10.  Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline.

Authors:  G W Sullivan; H T Carper; W J Novick; G L Mandell
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.